The solution, given intravenously to help prevent blindness, was marketed and administered without Food and Drug Administration approval. Federal officials recalled the drug in April 1984, after about five months on the market. Dozens of children suffered liver and kidney damage after taking the drug.
Attorney David Taylor, who represented the drug manufacturer and the distributor, says, "The product was recalled because it had collateral effects that were not intended."
